DUB3 is a MAGEA3 deubiquitinase and a potential therapeutic target in hepatocellular carcinoma
Article in iScience (February 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis
Article in Journal for ImmunoTherapy of Cancer (December 2023)
Advances, opportunities and challenges in developing therapeutic cancer vaccines
Article in Critical Reviews in Oncology/Hematology (November 2023)